The present invention provides a compound having a calcium-sensitive
receptor antagonistic action, a pharmaceutical composition containing the
compound, particularly a calcium receptor antagonist and a therapeutic
drug for osteoporosis. A compound represented by the following formula
(1), a pharmaceutically acceptable salt thereof or an optically active
form thereof: ##STR00001## wherein each symbol is as defined in the
description.